Crinetics Pharmaceuticals Inc.

This study follows patients with acromegaly who previously participated in earlier trials of the oral medication paltusotine. The main goal is to monitor long-term safety and side effects of continued treatment. Researchers will also track hormone levels to see if the drug contin…

This study is testing if a daily pill called paltusotine can safely maintain control of acromegaly in people who are already stable on standard injectable treatments. About 58 adults will be randomly assigned to either keep taking the pill or switch to a placebo (inactive pill) f…

This study is testing whether a new oral medication called paltusotine can safely control the hormone levels and symptoms of acromegaly. It involves 111 adults with acromegaly who are not currently on other drug treatments. Participants are randomly assigned to receive either the…